GlobeImmune

Read more
Jeffrey Dekker's photo - President of GlobeImmune

President

Jeffrey Dekker

CEO Approval Rating

69/100

Founded:

1995

Status:

PublicIndependent CompanyOTCMKTSGBIM

GLOBEIMMUNE TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Jeffrey Dekker

President

- -
2
$96.2M
$6.2M
View Profile
1

John Lewicki

President & CEO

75/100
22
$226.9M
$44.4M
View Profile
2

Ivan Bergstein

President & CEO

87/100
100
$48.3M
$47M
View Profile
3

Brian Stuglik

CEO

66/100
169
$234.2M
$80.7M
View Profile
4

Brian Roberts

President & CEO

77/100
45
$142.4M
$8.9M
View Profile
5

Michael P. Bailey

President & CEO

83/100
17
$379.4M
$7.2M
View Profile
6

Michael S. Weiss

Chairman & CEO

89/100
105
$128.1M
$ < 1M
View Profile
7

Sean A. McCarthy

Chairman & CEO

91/100
137
$290.6M
$66.7M
View Profile
8

Daniel P. Gold

President & CEO

95/100
40
$119.2M
$40.9M
View Profile
9

Alexander Hardy

CEO

79/100
13,638
$2B
$18.3B
View Profile
10

Garo H. Armen

Chairman & CEO

81/100
294
$352.2M
$84.8M
View Profile

Missing a competitor? Contribute!

GlobeImmune Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$6.2M

GlobeImmune's revenue is the ranked 23th among it's top 10 competitors. The top 10 competitors average 2.3B. Over the last four quarters, GlobeImmune's revenue has decreased by 26.2%. Specifically, in Q1 2016's revenue was $ < 1M; in Q4 2015, it was $1M; in Q3 2015, it was $2.9M; in Q2 2015, GlobeImmune's revenue was $1.3M.

GlobeImmune Acquisitions

No recent acquisitions found related to GlobeImmune

GlobeImmune Funding History

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Equity
Mar 2017
$2.1M
-
IPO
Jul 2014
$15M

Unattributed
Jan 2014
$7.5M
-
Unattributed
Nov 2013
$391.7K
-
Series E
Jan 2010
$17.5M
-

GlobeImmune Investments

No recent investments found related to GlobeImmune

GlobeImmune News

GlobeImmune Press Releases

Social Media

GlobeImmune Headquarters

1450 Infinite Drive

Louisville, Colorado80027

303-625-2700

Driving Directions »

Trending Companies

GlobeImmune Summary

ABOUT

Overview

GlobeImmune is engaged in the development of therapeutic Tarmogen vaccines for the treatment of cancer and infectious diseases. GlobeImmune was founded in 1995. GlobeImmune's headquarters is located in Louisville, Colorado, USA 80027. It has raised 96...

CEO

GlobeImmune's President, Jeffrey Dekker, currently has an approval rating of 69%. GlobeImmune's primary competitors are OncoMed Pharmaceuticals, Stemline & Verastem.

Frequently Asked Questions about GlobeImmune

  1. When was GlobeImmune founded?

    GlobeImmune was founded in 1995
  2. Who is GlobeImmune's CEO?

    GlobeImmune's CEO is Jeffrey Dekker
  3. How much revenue does GlobeImmune generate?

    GlobeImmune generates $6.2M in revenue
  4. How much funding does GlobeImmune have?

    GlobeImmune has historically raised $96.2M in funding
  1. Where is GlobeImmune's headquarters?

    GlobeImmune's headquarters is in Louisville Colorado, USA
  2. How many employees does GlobeImmune have?

    GlobeImmune has 2 employees
  3. What sector does GlobeImmune operate in?

    GlobeImmune is in Pharmaceuticals, Biotechnology
  4. Who are GlobeImmune's competitors?

    GlobeImmune's top competitors are OncoMed Pharmaceuticals, Stemline, Verastem